Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa

References

• Vieusseux M. Mιmoire sur la maladie qui a regnι a Genκve au printemps de 1805 [Memoir on the disease which reigned at Geneva in the spring of 1805]. J Med Chir Pharmacol. 1805;11:163.
   Google Scholar
• Weichselbaum A. Ueber die Aetiologie der akuten Meningitis cerebrospinalis [On the etiology of acute meningitis cerebrospinalis]. Fortschr Med. 1887;5:573–83.
   Google Scholar
• Marchiafava E, Celli A. Spra i micrococchi della meningite cerebrospinale epidemica. Gazz degli Ospedali. 1884;5:59.
   Google Scholar
• Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341–53. doi:10.1016/S0035-9203(99)90106-2
   PubMed Web of Science ®Google Scholar
• Nicolas P, Chippaux JP, Martet G. Epidemic of meningococcal meningitis in Africa in 1996: current data. Med Trop (Mars). 1996;56(2):203–4.
   PubMedGoogle Scholar
• Frasch CE. Recent developments in Neisseria meningitidis group A conjugate vaccines. Expert Opin Bio Ther. 2005;5(2):273–80.10.1517/14712598.5.2.273
   PubMed Web of Science ®Google Scholar
• Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341–53. doi:10.1016/S0035-9203(99)90106-2
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Multi Disease Surveillance Center (MDSC), WHO/African region. Meningitis Weekly Bulletin. [cited 2016 Dec 5]. Available from: http://www.meningvax.org/files/BulletinMeningite2009_S49_53.pdf
   Google Scholar
• Iliyasu G, Lawal H, Habib AG, et al. Response to the meningococcal meningitis epidemic (MME) at Aminu Kano Teaching Hospital, Kano (2008-2009). Niger J Med. 2009;18(4):428–30.
   PubMedGoogle Scholar
• World Health Organisation. Meningococcal disease in countries of the African meningitis belt, 2012 – emerging needs and future perspectives. Wkly Epidemiol Rec. 2013;88:129–36.
   PubMedGoogle Scholar
• World Health Organisation. Preparedness for outbreaks of meningococcal meningitis due to Neisseria meningitidis serogroup C in Africa: recommendations from a WHO expert consultation. Wkly Epidemiol Rec. 2015;90:633–6.
   PubMedGoogle Scholar
• Funk A, Uadiale K, Kamau C, et al. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013–2014. PLoS Curr. 2014 Dec;29:6. doi:10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518
   Google Scholar
• Whittle HC, Evans-Jones G, Onyewotu I, et al. Group C meningococcal meningitis in the northern savanna of Africa. Lancet. 1975;305(7921):1377.10.1016/S0140-6736(75)92281-3
   Google Scholar
• Umaru ET, Ludin ANM, Majid MR, et al. Risk factors responsible for the spread of meningococcal meningitis: a review. Int J Edu Res. 2013;1:1–30.
   Google Scholar
• Greenwood BM, Bradley AK, Cleland PG, et alet al. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features. Trans R Soc Trop Med Hyg. 1979;73:557–62.10.1016/0035-9203(79)90052-X
   PubMed Web of Science ®Google Scholar
• Bosmans E, Vimont-Vicary P, Andre FE, et al. Protective efficacy of bivalent (A +C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Ann Soc Belg Med Trop. 1980;60:297–306.
   PubMedGoogle Scholar
• Broome CV, Rugh MA, Yada AA, et al. Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bull World Health Organ. 1983;61(2):325–30.
   PubMed Web of Science ®Google Scholar
• Soro BN, Rey JL, Davis CE, et al. Elements d’tpidemiologie des menin-gites dans le nord de la Cote-d’Ivoire [Elements of epidemiology of meningitis in northern Cote d'Ivoire]. Med Trop. 1988;48:145–48.
   PubMedGoogle Scholar
• Spiegel A, Greindl Y, Lippeveld T, et al. Effect of two vaccination strategies on developments during the epidemic of meningococcal A meningitis in N’Djamena (Chad) in 1988. Bull World Health Organ. 1993;71:311–5.
   PubMed Web of Science ®Google Scholar
• Salih MA, Ahmed HS, Karrar ZA, et al. Features of a large epidemic of group A meningococcal meningitis in Khartoum, Sudan in 1988. Scand J Infect Dis. 1990;22(2):161–70.10.3109/00365549009037897
   PubMed Web of Science ®Google Scholar
• Habte-Gabr E, Muhe L, Mamo M. Meningococcal meningitis in Ethiopia 1974–1983 and strategies of control. Ethiop J Health Dev. 1984;1:47–63.
   Google Scholar
• Haimanot RT, Caugant DA, Fekadu D, et al. Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988–1989. Scand J Infect Dis. 1990;22:171–4.10.3109/00365549009037898
   PubMed Web of Science ®Google Scholar
• Pinner RW, Onyango F, Perkins BA, et al. Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) meningitis study group. J Infect Dis. 1992;166(2):359–64.10.1093/infdis/166.2.359
   PubMed Web of Science ®Google Scholar
• Varaine F, Caugant DA, Riou JY, et al. Meningitis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg. 1997;91(1):3–7.10.1016/S0035-9203(97)90371-0
   PubMed Web of Science ®Google Scholar
• Control of epidemic meningococcal disease, WHO practical guidelines. World Health Organization, 1998, 2nd edition, WHO/EMC/BAC/98.3. [ cited 2014 Jul 6]. Available from: http://www.who.int/csr/resources/publications/meningitis/whoemcbac983.pdf.
   Google Scholar
• World Health Organisation. Response to epidemic meningitis in Africa. Wkly Epidemiol Rec. 1997;72:313–8.
   PubMedGoogle Scholar
• Chippaux JP, Mounkaila A, Mounkaila N, et al L’épidémie de méningite cérébro-spinale du Niger de 1995 [The cerebro-spinal meningitis epidemic of Niger 1995]. O.C.C.G.E. Inf. 1996;105:9–12.
   Google Scholar
• World Health Organization. Meningococcal meningitis. Wkly Epidemiol Rec. 1995;70(19):136–7.
   Google Scholar
• Mohammed I, Nasidi A, Alkali AS, et al. A severe epidemic of meningococcal meningitis in Nigeria, 1996. Trans R Soc Trop Med Hyg. 2000;94(3):265–70.10.1016/S0035-9203(00)90316-X
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Meningococcal meningitis. Wkly Epidemiol Rec. 2003;78(33):294–6.
   PubMedGoogle Scholar
• World Health Organisation. Meningococcal meningitis. Wkly Epidemiol Rec. 2010;85(8):57–68.
   Google Scholar
• World Health Organisation. Meningococcal meningitis. Wkly Epidemiol Rec. 2013;88(12):129–36.
   PubMedGoogle Scholar
• Chow J, Uadiale K, Bestman A, et al. Invasive meningococcal meningitis serogroup C outbreak in Northwest Nigeria, 2015 – third consecutive outbreak of a new strain. PLOS Curr Outbreaks. 2016. doi:10.1371/currents.outbreaks.06d10b6b4e690917d8b0a04268906143
   Google Scholar
• World Health Organization. Meningococcal disease – Niger (Update). Disease Outbreak News. 2015 Jul 23. [cited 2016 Jul 24].
   Google Scholar
• Davey TH, Wilson T, editors. Control of disease in the tropics. London: H. K Lewis; 1965. 99 p.
   Google Scholar
• Hassan-King M, Greenwood BM, Whittle HC, et al. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 3. Meningococcal carriage Trans R Soc Trop Med Hyg 1979;73:567–7310.1016/0035-9203(79)90054-3
   PubMed Web of Science ®Google Scholar
• Lapeyssonnie L. Cerebrospinal meningitis in Africa. Bull World Health Org. 1963; 28:(suppl):3–5.
   Google Scholar
• Erwa HH, Haseeb MA, Idris AA, et al. A serogroup A meningococcal polysaccharide vaccine. Studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Bull World Health Org. 1973;49:301–5.
   PubMed Web of Science ®Google Scholar
• Ettori D, Soliou P, Renandet J, et al. Le vaccin anti-méningococcique du type A. premiers essais contrôlés en Afrique de L’Ouest. Med Trop. 1977;37:225–30.
   Google Scholar
• Wahdan MH, Rizk F, el-Akkad AM, et al. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull WHO. 1973;48(6):667–73.
   PubMed Web of Science ®Google Scholar
• Wahdan MH, Sallam SA, Hassan MN, et al. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bull WHO. 1977;55(6):645–51.
   PubMed Web of Science ®Google Scholar
• WHO Working Group. Control of epidemic meningococcal disease: WHO practical guidelines. Lyon: Fondation Marcel Merieux; 1998.
   Google Scholar
• Mohammed I, Damisah MM. The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria. Trans R Soc Trop Med Hyg. 1982;76(3):351–3. doi:10.1016/0035-9203(82)90188-2
   PubMed Web of Science ®Google Scholar
• Maiden MC, Ibarz-Pavón AB, Urwin R, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008;197:737–43. doi:10.1086/527401
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe 2008/2009. Stockholm: ECDC; 2011.
   Google Scholar
• Frasch CE, Preziosi MP, LaForce FM. Development of a group A meningococcal conjugate vaccine, MenAfriVac. Hum Vaccin Immunother. 2012;8:715–24.10.4161/hv.19619
   PubMed Web of Science ®Google Scholar
• Djingarey MH, Diomandé FVK, Barry R, et al. Introduction and rollout of a new group a meningococcal conjugate vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014. CID. 2015:61 (Suppl 5):434–41. doi:10.1093/cid/civ551
   PubMed Web of Science ®Google Scholar
• Meningovaccine.org website.
   Google Scholar
• WHO/PATH Meningitis Vaccine Project. Press release: dramatic fall in cases of meningitis A in three West African nations after new vaccine introduction. 2011;1–3. Available from: http://www.afro.who.int/en/media-centre/pressreleases/item/8360-meningitis-a-nearly-eliminated-in-africa-through-vaccination. ( Access 30th December 2016)
   Google Scholar
• Kristiansen PA, Diomandé F, Ba AK, et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2013;56:354–63.10.1093/cid/cis892
   PubMed Web of Science ®Google Scholar
• Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet. 2013;383(9911):40–7. doi:10.1016/S0140-6736(13)61612-8
   PubMed Web of Science ®Google Scholar
• Mohammed I, Obineche EN, Onyemelukwe GC, et al. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria. J Infect. 1984;9(2):190–6.10.1016/S0163-4453(84)91429-4
   PubMed Web of Science ®Google Scholar
• Binkin N, Band J. Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy. Lancet. 1982;320(8293):315–8.10.1016/S0140-6736(82)90282-3
   Google Scholar
• Varaine F, Caugant DA, Riou JY, et al. Meningitis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg. 1997;91:3–7.10.1016/S0035-9203(97)90371-0
   PubMed Web of Science ®Google Scholar
• Haelterman E, Boelaert M, Suetens C, et al. Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. Trop Med Int Health. 1996;I(3):385–92.10.1046/j.1365-3156.1996.d01-49.x
   Web of Science ®Google Scholar
• World Health Organisation. Meningococcal meningitis. Wkly Epidemiol Rec. 1996;71(18):133–40.
   PubMedGoogle Scholar
• Merlin M, Martet G, Debonne JM, et al. Control of an epidemic of meningococcal meningitis in Central Africa. Sante. 1996;6(2):87–95.
   PubMedGoogle Scholar
• Aplogan A, Batchassi E, Yakoua Y, et al. An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies. Sante. 1997;7(6):384–90.
   PubMedGoogle Scholar
• Merlin M, Martet G, Debonne JM, et al. Control of an epidemic of meningococcal meningitis in Central Africa. Sante. 1996;6(2):87–95.
   PubMedGoogle Scholar
• Aplogan A, Batchassi E, Yakoua Y, et al. An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies. Sante. 1997;7(6):384–90.
   PubMedGoogle Scholar
• World Health Organisation. Meningococcal disease. Wkly Epidemiol Rec. 1999;74(9):65–72.
   PubMedGoogle Scholar
• World Health Organisation. Meningococcal disease. Wkly Epidemiol Rec. 2015;90(13):121–32.
   PubMedGoogle Scholar
• World Health Organisation. Meningococcal disease. Wkly Epidemiol Rec. 2016;91(16):209–16.
   PubMedGoogle Scholar
• Artenstein MS, Gold R, Zimmerly JG, et al. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970;282:417–20.10.1056/NEJM197002192820803
   PubMed Web of Science ®Google Scholar
• Mohammed I, Onyemelukwe GC, Obineche EN, et al. Control of epidemic meningococcal meningitis by mass vaccination II. Persistence of antibody four years after vaccination. J Infect. 1984;9:I97–202.
   Google Scholar
• Mohammed I, Zaruba K. Control of epidemic meningococcal meningitis by mass vaccination. Lancet. 1981;318(8237):80–3.10.1016/S0140-6736(81)90423-2
   Google Scholar
• WHO Inter-country Support Team West Africa. WHO Meningitis Weekly Bulletin. [cited 2016 Jun 18]. Available from: wwwwhoint/csr/disease/meningococcal/epidemiological/en
   Google Scholar
• Dellicour S, Greenwood B. Systematic review: impact of meningococcal vaccination on pharyngeal carriage of meningococci. Trop Med Int Health. 2007;12:1409–21.10.1111/j.1365-3156.2007.01929.x
   PubMed Web of Science ®Google Scholar
• Reingold AL, Broome CV, Hightower AW. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet. 1985;326:114–8.10.1016/S0140-6736(85)90224-7
   Google Scholar
• Findlow H, Sow S, Borrow R, et al. Meningococcal group C and W135 immunological hyporesponsiveness in African toddlers. Clin Vaccine Immunol. 2011;18:1492–6.10.1128/CVI.05020-11
   PubMed Web of Science ®Google Scholar
• Hassan-King MK, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect. 1988;16:55–9.10.1016/S0163-4453(88)96117-8
   PubMed Web of Science ®Google Scholar
• WHO Inter-country Support Team – WestAfrica. WHO Meningitis Weekly Bulletin. [cited 2016 Jul 27]. Available from: wwwwhoint/csr/disease/meningococcal/epidemiological/en
   Google Scholar
• LaForce FM, Konde K, Viviani S, et al. The meningitis vaccine project. Vaccine. 2007;25(Suppl):A97–A100.10.1016/j.vaccine.2007.04.049
   Google Scholar
• Kshirsagar N, Mur N, Thatte U, et al. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults. Vaccine. 2007;25S:101–7.10.1016/j.vaccine.2007.04.050
   Web of Science ®Google Scholar
• Sow SO, Okoko BJ, Diallo A, et al. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med. 2011;364:2293–304.10.1056/NEJMoa1003812
   PubMed Web of Science ®Google Scholar
• Novak RT, Kambou JL, Diomandé FV, et al. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis. 2012;12:757–64. doi:10.1016/S1473-3099(12)70168-8
   PubMed Web of Science ®Google Scholar
• Molesworth AM, Thomson MC, Connor SJ, et al. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg. 2002;96(3):242–9.10.1016/S0035-9203(02)90089-1
   PubMed Web of Science ®Google Scholar
• Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(Suppl 2):B51–B63.10.1016/j.vaccine.2009.04.063
   PubMed Web of Science ®Google Scholar
• Marc LaForce F, Ravenscroft N, Djingarey M, et al. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. Vaccine. 2009;27(Suppl 2):B13–B19.10.1016/j.vaccine.2009.04.062
   PubMed Web of Science ®Google Scholar
• Control of Epidemic Meningococcal Disease, WHO Practical Guidelines. Second edition. 1998. Available from: http://www.who.int/csr/resources/publications/meningitis/whoemcbac983.pdf
   Google Scholar
• World Health Organisation. Meningococcal disease. Wkly Epidemiol Rec. 2015;90(13):121–32.
   PubMedGoogle Scholar
• Collard JM, Issaka B, Zaneidou M, et al. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis. 2013;13:43.10.1186/1471-2334-13-576
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Medah I, Koussoubé D, et al. Neisseria meningitidis serogroup W, Burkina Faso, 2012. Emerg Infect Dis. 2014;20(3):394–9.
   PubMed Web of Science ®Google Scholar
• Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]. Lancet. 2014;383(9911):40–7.10.1016/S0140-6736(13)61612-8
   PubMed Web of Science ®Google Scholar
• Boisier P, Nicolas P, Djibo S, et al. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis. 2007;44(5):657–63.10.1086/511646
   PubMed Web of Science ®Google Scholar
• Gagneux SP, Hodgson A, Smith TA, et al. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis. 2002;185(5):618–26.10.1086/jid.2002.185.issue-5
   PubMed Web of Science ®Google Scholar
• Koumaré B, Ouedraogo-Traoré R, Sanou I, et al. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Vaccine. 2007;25(Suppl 1):A37–A41.10.1016/j.vaccine.2007.04.038
   Google Scholar
• Djibo S, Nicolas P, Alonso JM, et al. Outbreaks of serogroup X meningococcal meningitis in Niger 1995–2000. Trop Med Int Health. 2003;8(12):1118–23.10.1046/j.1360-2276.2003.01126.x
   PubMed Web of Science ®Google Scholar
• Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002–2005. Clin Infect Dis. 2006;43(7):817–22.10.1086/cid.2006.43.issue-7
   PubMed Web of Science ®Google Scholar